Karolinska Institutet
Department of Neurobiology, Care Sciences and Society
Makoto Shimozawa is currently a Postdoctoral researcher in Per Nilsson group at Karolinska Institutet, Sweden. He has been assigned the current position since 2019. His research focuses on the role of autophagy in Alzheimer’s disease (AD) development. He is analyzing the role of autophagy in metabolism and spreading of amyloid beta peptide and tau protein using AD mouse models. He earned his PhD in life sciences from Tokyo University of Pharmacy and Life Sciences in 2018. From 2010-2015, he worked on clinical trial management including AD therapeutics in Novartis Pharma K.K. in Japan. He was selected as a top 10% excellent PhD student from Japan Student Services Organization in 2018.

Presenter of 1 Presentation

TRANSCRIPTOME ANALYSIS OF HIPPOCAMPUS OF APP KNOCK-IN ALZHEIMER MOUSE MODELS REVEALS AUTOPHAGY IMPAIRMENT LINKED WITH SYNAPTIC DYSFUNCTION

Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
02:45 PM - 04:30 PM
Room
ONSITE: 131-132
Lecture Time
03:45 PM - 04:00 PM

Abstract

Aims

Alzheimer Disease (AD) is a neurodegenerative disorder characterized by impaired protein homeostasis. Autophagy is a major clean up system which is impaired in AD leading to an increase of autophagosomes in dystrophic neurites. The aim of this study is to understand the development of autophagy impairment associated with Aβ deposition and the link between autophagy impairment and other AD related pathologies.

Methods

We performed RNA-sequencing analysis of hippocampus from App knock-in mouse models at three different ages to compare and evaluate the early as well as the more advanced stages of neuropathological changes. Autophagy flux was measured in the crude synaptosomal fractionations of hippocampus, and autophagosome accumulation was investigated by immunofluorescence (IF) staining and electron microscopy. We also performed IF staining of tau in autophagy-deficient mouse brain.

Results

We sequenced approximately 46,000 transcripts. Pathway analysis revealed that pathways regulating autophagy were slightly up-regulated before onset of pathology, and it gradually decreased at late stage in AppNL-G-F mice mimicking the processes present in AD brain. We found an accumulation of autophagosomes in 12-months-old AppNL-G-F mice but not in 2-months-old. Interestingly, swollen synapses containing autophagosomes were observed in 12-months-old AppNL-G-Fmice. It may indicate a link between autophagy impairment and synaptic dysfunction. We also revealed phosphorylated tau accumulation in hippocampus of autophagy-deficient mice.

Conclusions

We revealed autophagy impairment in App knock-in mouse models. Autophagy impairment may have a link with other AD related pathologies such as synaptic dysfunction and tau pathology.

Hide